| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-21 | SCHEDULE 13D | Research Alliance Holdings IV LLC | — | 1,538,529 | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-16 | SCHEDULE 13D/A | XOMA Royalty Corp | — | 0 | view → |
| 2026-07-10 | SCHEDULE 13G | Pyxis Oncology, Inc. PYXS | — | — | view → |
| 2026-06-29 | SCHEDULE 13D/A | MoonLake Immunotherapeutics MLTX | 19.70% | 8,302,735 | view → |
| 2026-06-26 | SCHEDULE 13D/A | Kymera Therapeutics, Inc. KYMR | 6.30% | 2,712,852 | view → |
| 2026-06-04 | SCHEDULE 13G | Q32 Bio Inc. QTTB | — | — | view → |
| 2026-05-29 | SCHEDULE 13G | Research Alliance Corp III RACC | — | — | view → |
| 2026-05-27 | SCHEDULE 13G | OnKure Therapeutics, Inc. OKUR | — | — | view → |
| 2026-05-18 | SCHEDULE 13D/A | XOMA Royalty Corp XOMAP | — | 3,635,758 | view → |
| 2026-04-02 | SCHEDULE 13D/A | MoonLake Immunotherapeutics MLTX | 22.30% | 8,302,735 | view → |
| 2025-11-24 | SCHEDULE | Repare Therapeutics Inc. | 24.00% | 10,333,600 | view → |
| 2025-05-20 | SCHEDULE | XOMA Royalty Corp XOMAP | 21.60% | 2,590,303 | view → |
| 2025-01-28 | SCHEDULE | XOMA Royalty Corp XOMAP | 25.30% | 2,983,026 | view → |
| 2024-10-08 | SC | MoonLake Immunotherapeutics MLTX | — | — | view → |
| 2024-07-19 | SC | Inventiva S.A. IVEVF | — | — | view → |
| 2024-01-29 | SC | Rain Oncology Inc. | — | — | view → |
| 2024-01-09 | SC | Kymera Therapeutics, Inc. KYMR | — | — | view → |
| 2023-12-18 | SC | Rain Oncology Inc. | — | — | view → |
| 2023-06-30 | SC | MoonLake Immunotherapeutics MLTX | — | — | view → |
| 2022-01-11 | SC | Rain Therapeutics Inc. | — | — | view → |
| 2021-09-15 | SC | Rain Therapeutics Inc. | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →